Diabetes-focused Microbiome Therapeutics raises $1.3M to test meds that alter gut bacteria

Diabetes-focused Microbiome Therapeutics raises $1.3M to test meds that alter gut bacteria:

gut bacteria prebiotics

David G. Armstrong

Dedicated to amputation prevention, wound healing, diabetic foot, biotechnology and the intersection between medical devices and consumer electronics.

Leave a Reply